COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...

AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China.

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...

The decision to pause its investment in Britain came as AstraZeneca announced plans to spend $3.5bn (£2.7bn) expanding its US ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

GlaxoSmithKline has announced plans to collaborate with China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 coronavirus. The companies are testing a recombinant protein-based ...

AstraZeneca disclosed Wednesday that Leon Wang, a high-ranking executive who oversees international operations and is also president of its subsidiary in China, is under investigation by Chinese ...

Overall, Denmark and Ireland were the only two countries to exceed 75 per cent flu vaccination coverage for people aged 65 and over. This means countries are falling behind the European Council ...

Sales of Pfizer’s new vaccine for respiratory syncytial virus were lower in ... Both shots would provide additional coverage against pneumococcal disease, but Pfizer has competitors. Merck & Co.

Wellness add-ons with vaccine coverage cost extra and operate separately from standard pet insurance plans with different rules and procedures. We collected quotes for five cats and five dogs ...